Profile data is unavailable for this security.
About the company
Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.
- Revenue in USD (TTM)4.49bn
- Net income in USD-1.29bn
- Incorporated2000
- Employees10.59k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
- Websitehttps://www.illumina.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Badger Meter Inc | 740.77m | 102.31m | 5.87bn | 2.14k | 57.52 | 10.96 | 44.63 | 7.92 | 3.47 | 3.47 | 25.13 | 18.22 | 1.08 | 3.07 | 8.39 | 346,154.70 | 14.86 | 12.26 | 18.17 | 14.60 | 39.26 | 39.38 | 13.81 | 12.06 | 2.30 | -- | 0.00 | 36.36 | 24.40 | 10.16 | 39.25 | 27.22 | 6.79 | 12.07 |
| Vontier Corp | 3.07bn | 430.90m | 6.18bn | 8.00k | 14.46 | 6.28 | 11.10 | 2.01 | 2.77 | 2.77 | 19.73 | 6.37 | 0.7163 | 5.03 | 6.21 | 384,325.00 | 10.04 | 10.80 | 12.63 | 14.04 | 47.17 | 44.62 | 14.01 | 13.36 | 1.23 | 6.23 | 0.6935 | 2.24 | -2.80 | 3.03 | -6.08 | -0.5018 | 7.23 | -- |
| Cognex Corp | 847.22m | 99.64m | 8.19bn | 2.99k | 83.00 | 5.50 | 65.69 | 9.67 | 0.5749 | 0.5749 | 4.90 | 8.68 | 0.425 | 1.66 | 5.72 | 283,161.80 | 5.00 | 10.63 | 5.56 | 11.56 | 70.75 | 72.97 | 11.76 | 22.38 | 2.61 | -- | 0.00 | 57.03 | -16.75 | 0.7624 | -47.46 | -13.24 | -9.06 | 9.03 |
| Bio Rad Laboratories Inc | 2.61bn | -322.37m | 8.23bn | 8.03k | -- | 0.9147 | -- | 3.16 | -10.36 | -10.36 | 89.91 | 317.32 | 0.1983 | 1.58 | 5.52 | 324,438.10 | -2.45 | 9.08 | -2.56 | 9.60 | 53.53 | 55.55 | -12.37 | 41.97 | 4.89 | 0.4496 | 0.117 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
| MKS Instruments Inc | 3.70bn | -1.78bn | 8.64bn | 10.00k | -- | 3.56 | -- | 2.34 | -26.71 | -26.71 | 55.13 | 36.13 | 0.3641 | 1.94 | 6.07 | 369,500.00 | -17.58 | -1.60 | -19.08 | -1.75 | 46.60 | 44.95 | -48.28 | -3.25 | 2.34 | 1.45 | 0.6617 | -- | 2.11 | 11.78 | -652.85 | -- | 6.69 | 2.44 |
| Bruker Corp | 3.00bn | 401.60m | 11.15bn | 9.71k | 27.93 | 7.88 | 21.19 | 3.71 | 2.75 | 2.75 | 20.44 | 9.74 | 0.7257 | 1.55 | 6.34 | 309,148.00 | 9.71 | 8.38 | 13.45 | 11.40 | 50.43 | 49.85 | 13.38 | 11.39 | 0.9132 | 179.75 | 0.4872 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Revvity Inc | 2.73bn | 183.35m | 13.81bn | 11.50k | 75.78 | 1.76 | 22.49 | 5.07 | 1.48 | 1.21 | 21.96 | 63.54 | 0.1942 | 2.87 | 4.64 | 237,011.00 | 1.31 | 4.76 | 1.46 | 5.39 | 55.52 | 57.19 | 6.73 | 15.34 | 1.92 | 6.11 | 0.3307 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Avantor Inc | 6.87bn | 260.00m | 16.42bn | 14.50k | 63.20 | 3.08 | 24.86 | 2.39 | 0.3826 | 0.3826 | 10.12 | 7.86 | 0.525 | 5.32 | 5.71 | 473,565.50 | 1.99 | 2.97 | 2.26 | 3.35 | 33.63 | 33.44 | 3.79 | 5.06 | 1.05 | 3.03 | 0.4994 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Illumina Inc | 4.49bn | -1.29bn | 16.86bn | 10.59k | -- | 2.94 | -- | 3.75 | -8.15 | -8.15 | 28.39 | 36.06 | 0.4112 | 2.97 | 6.75 | 424,268.20 | -11.80 | -6.20 | -14.21 | -7.28 | 61.36 | 66.39 | -28.69 | -15.48 | 1.36 | -- | 0.2063 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Waters Corp | 2.91bn | 603.51m | 19.98bn | 7.90k | 33.06 | 15.90 | 25.39 | 6.87 | 10.19 | 10.19 | 49.09 | 21.19 | 0.7443 | 2.26 | 4.44 | 368,174.80 | 15.44 | 19.77 | 19.58 | 25.29 | 59.68 | 58.45 | 20.75 | 23.38 | 1.30 | 8.46 | 0.6207 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Veralto Corp | 5.04bn | 798.00m | 24.65bn | 16.00k | 30.90 | 16.63 | 27.88 | 4.89 | 3.23 | 3.23 | 20.42 | 6.00 | 0.9556 | 6.40 | 6.17 | 315,125.00 | 15.12 | -- | 19.09 | -- | 58.31 | -- | 15.83 | -- | 1.56 | 19.98 | 0.6376 | -- | 3.10 | -- | -0.7101 | -- | -- | -- |
| Keysight Technologies Inc | 5.17bn | 812.00m | 25.11bn | 15.50k | 31.48 | 5.12 | 23.82 | 4.86 | 4.57 | 4.57 | 29.16 | 28.08 | 0.5841 | 1.88 | 6.18 | 346,845.60 | 9.18 | 11.69 | 11.37 | 14.21 | 64.16 | 62.09 | 15.71 | 17.75 | 1.48 | -- | 0.268 | 0.00 | 0.8118 | 7.10 | -5.96 | 44.98 | 8.23 | -- |
Data as of May 23 2024. Currency figures normalised to Illumina Inc's reporting currency: US Dollar USD
40.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 17.57m | 11.06% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 9.17m | 5.77% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 6.81m | 4.29% |
| Edgewood Management LLCas of 31 Mar 2024 | 6.66m | 4.19% |
| Baillie Gifford & Co.as of 31 Mar 2024 | 5.74m | 3.61% |
| Loomis, Sayles & Co. LPas of 31 Mar 2024 | 4.41m | 2.78% |
| Geode Capital Management LLCas of 31 Mar 2024 | 3.75m | 2.36% |
| Janus Henderson Investors US LLCas of 31 Mar 2024 | 3.66m | 2.31% |
| WCM Investment Management LLCas of 31 Mar 2024 | 3.38m | 2.13% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 2.75m | 1.73% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
